MINI FUTURE LONG - EUROFINS SCIENTIFIC | Market Closed - Euronext Paris 08:50:32 30/04/2024 pm IST | ||
| 1.735 EUR | -5.96% |
|
| 1 month | -8.44% | ||
| 3 months | +4.83% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
EUROFINS SCIENTIFIC SE
Latest news about EUROFINS SCIENTIFIC SE
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 1.735 | -5.96% | 1,500 |
| 29/24/29 | 1.845 | +12.16% | 52 |
| 26/24/26 | 1.645 | -4.64% | 58 |
| 25/24/25 | 1.725 | +4.23% | 53 |
| 24/24/24 | 1.655 | -22.66% | 66 |
Real-time Euronext Paris
Last update April 30, 2024 at 08:50 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | EUROFINS SCIENTIFIC SE |
| Issuer | 
BNP Paribas
|
| 14XKB | |
| ISIN | FRBNPP0120T9 |
| Date issued | 28/06/2019 |
| Strike | 40.48 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.3456 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.16 € |
|---|---|
| Lowest since issue | 0.185 € |
Company Profile
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products.
At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world.
Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).
Sector
-
Consensus: Eurofins Scientific SE
Sell
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
57.6
EUR
Average target price
60.88
EUR
Spread / Average Target
+5.69%
- Stock Market
- Certificates
- 14XKB Certificat
